NCT07253766Completed
The Effectiveness of Kinesiologic Taping in Patients With Knee Rheumatoid Arthritis
The Effectiveness of Kinesiologic Taping in Patients With Knee Rheumatoid Arthritis in Terms of Pain, Function, and Kinesiophobia: A Randomised Controlled Trial
Source: ClinicalTrials.gov · Last updated 28 Nov 2025
Brief summary (registry, in English)
The goal of this clinical trial is to learn if kinesiologic taping works to treat individuals with Rheumatoid Arthritis. The main questions it aim to answer: * Is kinesiologic taping applied to the knee joint an effective treatment for pain, mobility, and kinesiophobia in individuals diagnosed with rheumatoid arthritis? * Which is more effective? Kinesiologic taping or non-therapeutic sham taping? Which is better for pain, functional capacity, kinesiophobia and disease activity? Researchers will compare kinesiologic taping and non-therapeutic sham taping . Patients will be randomly divided into groups. The first group of patients was treated with sham taping, and the application period was applied consecutively for 4 weeks, with a minimum interval of 3 days and a maximum interval of 5 days. Group 2 patients underwent kinesiological taping, with the application period ranging from 3 to 5 days per week for 4 consecutive weeks.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 18 Sept 2025
- Start date
- 1 Nov 2024
- Primary completion date
- 1 Apr 2025
- Lead sponsor
- Istanbul Rumeli University
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT07253766
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 1 Nov 2024 to the primary completion date, 1 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- individuals with neurological disorders, severe chronic obstructive pulmonary disease, liver or kidney failure, malignancies, uncontrolled diabetes mellitus, major psychiatric disorders, or pregnancy; and those with concomitant conditions that could cause balance problems.
- individuals who had undergone surgery in the last few months;
Other illness
- patients with loss of cooperation (e.g., those diagnosed with dementia or Alzheimer's disease) were also excluded from the study.
Age
- individuals over the age of 61;
Other
- Pregnant and breastfeeding women;
Who the study is looking for
- Patients aged 45 to 60
- Patients diagnosed with acute or chronic rheumatoid arthritis;
- Patients whose rheumatic medication protocol has not changed in the last 3 months; -Patients who do not smoke, drink alcohol or use drugs;
- Patients who have no vision, hearing or speech problems;
- Patients who are not amputees;
- Patients who can walk independently.
Age in the registry: 45 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul Rumeli University Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.